Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 89

1.

[Macrophage migration inhibitory factor (MIF), a regulator of neonatal innate immune response].

Giannoni É, Schneider A, Calandra T, Roger T.

Med Sci (Paris). 2016 Dec;32(12):1062-1064. doi: 10.1051/medsci/20163212006. French. No abstract available.

PMID:
28044966
2.

Frequent Occupational Exposure to Fusarium Mycotoxins of Workers in the Swiss Grain Industry.

Niculita-Hirzel H, Hantier G, Storti F, Plateel G, Roger T.

Toxins (Basel). 2016 Dec 12;8(12). pii: E370.

3.

Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.

Ciarlo E, Heinonen T, Herderschee J, Fenwick C, Mombelli M, Le Roy D, Roger T.

Sci Rep. 2016 Nov 29;6:37944. doi: 10.1038/srep37944.

4.

Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis.

Stalder G, Que YA, Calzavarini S, Burnier L, Kosinski C, Ballabeni P, Roger T, Calandra T, Duchosal MA, Liaudet L, Eggimann P, Angelillo-Scherrer A.

PLoS One. 2016 Oct 27;11(10):e0163542. doi: 10.1371/journal.pone.0163542.

5.

Innate immune defects in HIV permissive cell lines.

Rausell A, Muñoz M, Martinez R, Roger T, Telenti A, Ciuffi A.

Retrovirology. 2016 Jun 27;13(1):43. doi: 10.1186/s12977-016-0275-8.

6.
7.

Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.

Savva A, Brouwer MC, Roger T, Valls Serón M, Le Roy D, Ferwerda B, van der Ende A, Bochud PY, van de Beek D, Calandra T.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3597-602. doi: 10.1073/pnas.1520727113.

8.

Mouse Model of Respiratory Tract Infection Induced by Waddlia chondrophila.

Pilloux L, LeRoy D, Brunel C, Roger T, Greub G.

PLoS One. 2016 Mar 7;11(3):e0150909. doi: 10.1371/journal.pone.0150909.

9.

High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates.

Roger T, Schneider A, Weier M, Sweep FC, Le Roy D, Bernhagen J, Calandra T, Giannoni E.

Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E997-1005. doi: 10.1073/pnas.1514018113.

10.

Efficacy study of two novel hyaluronic acid-based formulations for viscosupplementation therapy in an early osteoarthrosic rabbit model.

Kaderli S, Viguier E, Watrelot-Virieux D, Roger T, Gurny R, Scapozza L, Möller M, Boulocher C, Jordan O.

Eur J Pharm Biopharm. 2015 Oct;96:388-95. doi: 10.1016/j.ejpb.2015.09.005.

PMID:
26369477
11.

T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.

Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, Conrad C, Gregorio J, Le Roy D, Roger T, Ladbury JE, Homey B, Watowich S, Modlin RL, Kontoyiannis DP, Liu YJ, Arold ST, Gilliet M.

Nat Immunol. 2015 Sep;16(9):970-9. doi: 10.1038/ni.3211.

12.

Innate Immune Sensing of Fusarium culmorum by Mouse Dendritic Cells.

Vacher G, Ciarlo E, Savova-Bianchi D, Le Roy D, Hantier G, Niculita-Hirzel H, Roger T.

J Toxicol Environ Health A. 2015;78(13-14):871-85. doi: 10.1080/15287394.2015.1051201.

PMID:
26167753
13.

Emerging single-cell technologies in immunology.

Herderschee J, Fenwick C, Pantaleo G, Roger T, Calandra T.

J Leukoc Biol. 2015 Jul;98(1):23-32. doi: 10.1189/jlb.6RU0115-020R. Review.

14.

Xanthine oxidoreductase regulates macrophage IL1β secretion upon NLRP3 inflammasome activation.

Ives A, Nomura J, Martinon F, Roger T, LeRoy D, Miner JN, Simon G, Busso N, So A.

Nat Commun. 2015 Mar 24;6:6555. doi: 10.1038/ncomms7555.

15.

Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.

Delaloye J, Filali-Mouhim A, Cameron MJ, Haddad EK, Harari A, Goulet JP, Gomez CE, Perdiguero B, Esteban M, Pantaleo G, Roger T, Sékaly RP, Calandra T.

J Virol. 2015 Apr;89(7):3819-32. doi: 10.1128/JVI.03061-14.

16.

Immune responses to airborne fungi and non-invasive airway diseases.

Vacher G, Niculita-Hirzel H, Roger T.

Semin Immunopathol. 2015 Mar;37(2):83-96. doi: 10.1007/s00281-014-0471-3. Review.

PMID:
25502371
17.

Oral cyclosporine A in neonatal swines for transplantation studies.

Pan H, Gazarian A, Buff S, Solla F, Gagnieu MC, Leveneur O, Watrelot-Virieux D, Morisset S, Sobh M, Michallet MC, Roger T, Dubernard JM, Michallet M.

Immunopharmacol Immunotoxicol. 2015 Feb;37(1):19-25. doi: 10.3109/08923973.2014.975818.

PMID:
25358107
18.

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M.

J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14.

19.

Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.

Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, Roger T, Lacabaratz C, Bart PA, Levy Y, Pantaleo G.

J Exp Med. 2014 Sep 22;211(10):2033-45. doi: 10.1084/jem.20140039.

20.

Ultrastructural analysis of healthy synovial fluids in three mammalian species.

Matei CI, Boulocher C, Boulé C, Schramme M, Viguier E, Roger T, Berthier Y, Trunfio-Sfarghiu AM, Blanchin MG.

Microsc Microanal. 2014 Jun;20(3):903-11. doi: 10.1017/S1431927614000415.

PMID:
24641871
Items per page

Supplemental Content

Loading ...
Support Center